IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN ECUADOR

被引：0
|
作者：
Lopez-Cabra, C. [1 ]
Rodriguez, A. D. [2 ]
Mogollon, Mayorga W. [2 ]
Chavez, M. A. [3 ]
Patino, A. [3 ]
Herran, S. E. [1 ]
Marrugo, R. [1 ]
机构：
[1] Bayer, Bogota, Cun, Colombia
[2] Numeris, Bogota, Colombia
[3] Bayer, San Jose, Cun, Costa Rica
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE196
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [1] IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN PERU
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mayorga, Mogollon W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S137 - S137
  • [2] IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN CENTRAL AMERICA
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, W. Mayorga
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S159 - S159
  • [3] BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) USING THE STANDARD OF CARE IN ECUADOR
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, Mayorga W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S74 - S74
  • [4] CHARACTERISTICS OF FINERENONE INITIATORS AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) AND TYPE 2 DIABETES (T2D)
    Teng, Chia-Chen
    Singh, Rakesh
    Kong, Sheldon
    Djaraher, Rachel
    Williamson, Todd
    Farej, Ryan
    Willey, Vincent
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S75 - S75
  • [5] BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) USING THE STANDARD OF CARE IN PERU
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, W. Mayorga
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S159 - S160
  • [6] Delayed Chronic Kidney Disease (CKD) Diagnosis in Type 2 Diabetes (T2D)
    Harindhanavudhi, Tasma
    Freese, Rebecca L.
    Caramori, Luiza
    [J]. DIABETES, 2021, 70
  • [7] BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) USING THE STANDARD OF CARE IN CENTRAL AMERICA
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, Mayorga W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S116 - S116
  • [8] Impact of Finerenone on Cardiac Biomarkers in Patients With T2D and Chronic Kidney Disease
    Berger, Mario
    Scalise, Andrea
    Kramer, Frank M.
    Paraschin, Karen
    Goea, Laura
    Kolkhof, Peter
    Rohwedder, Katja
    Skubala, Adam
    Voss, Sebastian
    Zannad, Faiez
    Rossing, Peter
    [J]. CIRCULATION, 2023, 148
  • [9] Physicians' Chronic Kidney Disease (CKD) Awareness over Time in Type 2 Diabetes (T2D)
    Schempf, John
    Freese, Rebecca L.
    Caramori, Luiza
    Harindhanavudhi, Tasma
    [J]. DIABETES, 2020, 69
  • [10] AWAREness of Diagnosis and Treatment of Chronic Kidney Disease in Adults With Type 2 Diabetes (AWARE-CKD in T2D)
    Chu, Lisa
    Bhogal, Sanjit K.
    Lin, Peter
    Steele, Andrew
    Fuller, Mark
    Ciaccia, Antonio
    Abitbol, Alexander
    [J]. CANADIAN JOURNAL OF DIABETES, 2022, 46 (05) : 464 - 472
12345